Technological and product‐market experience and the success of new product introductions in the pharmaceutical industry

Abstract

Abstract The growth and development of a firm depend on its ability to introduce new products over time. To do this successfully, it requires technological knowledge, the ability to combine knowledge elements into valuable new products, and the complementary assets that facilitate the manufacturing, sales, and distribution of those products. We argue that these all develop as a function of a firm's experience in its technological and product‐market domains. Moreover, given the prospect of complementarities among technological and product‐market experience, the value of any one type of experience may be enhanced by the presence of another. Therefore, new products will be more successful when a firm possesses the appropriate stocks of technological and product‐market experience. We test this idea by analyzing whether pharmaceutical firms' experience in their technological and product‐market domains confer early advantages to their new product offerings, and lead to higher initial sales levels. Copyright © 2004 John Wiley & Sons, Ltd.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 481 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.